On Monday, Geron Corp (NASDAQ: GERN) opened higher 3.41% from the last session, before settling in for the closing price of $4.11. Price fluctuations for GERN have ranged from $1.64 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 46.26% over the past five years. Company’s average yearly earnings per share was noted -6.25% at the time writing. With a float of $552.62 million, this company’s outstanding shares have now reached $602.80 million.
Let’s look at the performance matrix of the company that is accounted for 141 employees. In terms of profitability, gross margin is -2113.26%, operating margin of -16559.94%, and the pretax margin is -15990.68%.
Geron Corp (GERN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 8.32%, while institutional ownership is 69.77%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.1) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1869.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 5.48 million, a negative change from its year-to-date volume of 10.33 million. As of the previous 9 days, the stock’s Stochastic %D was 65.64%. Additionally, its Average True Range was 0.19.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 30.92%, which indicates a significant decrease from 86.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.05% in the past 14 days, which was lower than the 47.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.34, while its 200-day Moving Average is $3.76. Nevertheless, the first resistance level for the watch stands at $4.35 in the near term. At $4.44, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.63. If the price goes on to break the first support level at $4.07, it is likely to go to the next support level at $3.88. The third support level lies at $3.79 if the price breaches the second support level.
Geron Corp (NASDAQ: GERN) Key Stats
There are currently 602,796K shares outstanding in the company with a market cap of 2.56 billion. Presently, the company’s annual sales total 240 K according to its annual income of -184,130 K. Last quarter, the company’s sales amounted to 880 K and its income totaled -67,380 K.
